期刊文献+

老年心血管内科患者临床用药情况分析

Analysis of prescription medications in elderly patients with cardiovascular diseases
收藏 分享 导出
摘要 目的分析老年心血管内科患者的临床用药情况。方法抽取来我院就诊的386例老年心血管内科患者的病历,统计分析其用药情况。结果老年心血管内科患者常见病为高血压、冠心病、心律失常;治疗药物出现次数最多的是钙拮抗剂、血管紧张素转化酶抑制剂、中药复方制剂,用药比例分别达到28.2%、21.5%、19.4%;临床上多采用联合治疗的方式,四联、五联、六联及以上用药的比例分别为16.6%、21.2%、29.0%。结论临床老年心血管疾病的治疗多采用联合用药,在治疗过程中如何降低不良反应,提高联合用药的合理性和安全性是需要重视的问题。 Objective To analyze the clinical medications in elderly patients with cardiovascular diseases. Methods The medical records were extracted and statistically analyzed in 386 elderly patients with cardiovascular diseases in Department of Vasculocardiology of our hospital. Results The primary hypertension, coronary heart disease, and arrhythmias were the most common cardiovascular diseases in elderly patients. The most frequently prescribed medications were calcium channel blockers, angiotensin-converting enzyme inhibitors, and traditional Chinese medicine compound preparations, which accounted for 28.2%, 21.5% and 19.4%, respectively. The drug combination therapy is often used in clinical practice, and the proportion of four, five, ≥ six drugs combination therapy was 16.6 %,21.2 % and 29.0 %, respectively. Conclusions It is important to pay more attention to reducing adverse reactions and improving the rationality and safety of the drugs combination therapy in the treatment of senile cardiovascular diseases.
作者 杨树国 陈良华 Yang Shuguo,Chen Lianghua( The Second Department of Cardiovascular ,Central Hospital of Linyi City of Shandong Province, Linyi 276400, China ; Department of Cardiology, Shandong Provincal Hospital, Jinan 250021 ,China )
出处 《中华老年医学杂志》 CSCD 北大核心 2018年第10期1082-1084,共3页 Chinese Journal of Geriatrics
基金 山东省卫生厅资助项目:硫化氢在桥血管再狭窄中的保护作用及机制研究(2014WS0094)
关键词 心血管疾病 临床用药 Cardiovascular diseases Clinical medications application
作者简介 通信作者:陈良华,Email:liffchen@163.com
  • 相关文献

参考文献7

二级参考文献55

  • 1Ambroisine ML, Milliez P, Nehme J, et al. Aldosterone and anti-al- dosterone effects in cardiovascular diseases and diabetic nephropa- thy[J]. Diabetes Metab,2004,30(4) :311-318. 被引量:1
  • 2Brown NJ. Aldosterone and vascular inflammation [ J ]. Hyperten- sion ,2008,51 ( 2 ) : 161-167. 被引量:1
  • 3Luther JM, Gainer JV, Murphey LJ. Angiotensin Ⅱ induces inter- leukin-6 in humans through a mineralocorticoid receptor-dependent mechanism[ J]. Hypertension ,2006,48 ( 6 ) : 1050-1057. 被引量:1
  • 4Ferrari P. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease [ J ]. Neph- rology,2007,12( 1 ) :81-89. 被引量:1
  • 5Gasparo MDE, Levens NR. Pharmacology of angiotensin II receptor in the kidney [ J ]. Kidney Int, 1994,46 (6) : 1486-1491. 被引量:1
  • 6Remuzzi A, Perticucci E, Reggenenti P, et al. Angiotensin conver- ting enzyme inhibition improve glomarular size selecti-vity in IgA nephropathy [ J ]. Kidney Int, 1991,39 ( 6 ) : 1267-1273. 被引量:1
  • 7Woo KT, Lau YK, Wong KS, et al. ACE][/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephri- tis[ J]. Kidney Int,2000,58 ( 6 ) :2485-2491. 被引量:1
  • 8Nakao N,Yoshimura A, Morita H, et al. Combination treatment of angiotensin- II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease( COOPER ATE) :a random- ised controlled trial[ J ]. Lancet,2003,361 (9352) : 117-124. 被引量:1
  • 9Krum H,Carson P, Farsang C, et al. Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure:re- sults from Val-HeFT[ J]. Eur J HeartFail,2004,6(7) :937. 被引量:1
  • 10McMurray J J, Ostergren J, Swedberg K,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial [ J ]. Lancet,2003,362 (9386) : 767 -771. 被引量:1

共引文献738

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈